Company / Assets per Share
Anika Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$13.20
FY2025
5-year range
$13.20 / $24.25
FY2021-FY2025
Trend
-4.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 4 consecutive years, from $24.25 in FY2021 to $13.20 in FY2025.
Based on SEC 10-K filings.
13.20 in FY2025 with a 5-year CAGR of -10.6%.
Declined from $18.50 to $13.20 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -18.3%
- 5-Year CAGR
- -10.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Anika Therapeutics, Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 4.6% year-over-year.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.20 | -4.6% |
| FY2024 | $13.83 | -25.3% |
| FY2023 | $18.50 | -23.5% |
| FY2022 | $24.18 | -0.3% |
| FY2021 | $24.25 | +4.9% |
| FY2020 | $23.11 | -0.7% |
| FY2019 | $23.27 | +22.5% |
| FY2018 | $18.99 | -1.7% |
| FY2017 | $19.32 | +20.9% |
| FY2016 | $15.98 | +0.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026